Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children
- 25 July 2006
- journal article
- clinical trial
- Published by Wiley in Pediatrics International
- Vol. 48 (4) , 403-405
- https://doi.org/10.1111/j.1442-200x.2006.02229.x
Abstract
Molluscum contagiosum (MC) is caused by a poxvirus which produces cutaneous lesions appearing as small, firm, umbilicated papules. Lesions of MC are most commonly seen in young children. Transmission is through viral particles, which remain on surfaces, autoinoculation, or from contact with open lesions. There are many options for treatment of MC and these may be broadly subdivided into destructive, immunological and antiviral therapies. An alternative treatment would be desirable in pediatric patients. Imiquimod (IQ) is a member of immune response modifiers.Here, the results of 12 Turkish pediatric patients with MC who used IQ 5% cream (aged between 3-13 years; six boys, six girls) are given. The cream was applied by the mothers in the evening, three times per week every other day up to 16 weeks.One of the patients gave up the treatment because of Influenza-like symptoms, and two of them because of the progress in the lesions continued. In seven of the remaining nine patients, total recovery was achieved. Local side-effects in patients were well tolerated.When all the patients affected with MC who exclusively used IQ 5% cream as mentioned in the literature were studied, 35 of 83 patients (42.2%) had complete clearance. These have differences in the form and duration of application. IQ 5% cream can be preferred in the treatment of children with MC because of its applicability at home, easy application and good tolerability. However, different application methods and suitable treatment methods should be determined.Keywords
This publication has 15 references indexed in Scilit:
- Topical Imiquimod 5% Cream in External Anogenital Warts: A Randomized, Double‐Blind, Placebo‐Controlled StudyThe Journal of Dermatology, 2004
- Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosumBritish Journal of Dermatology, 2003
- Experience in treating molluscum contagiosum in children with imiquimod 5% creamBritish Journal of Dermatology, 2003
- ImiquimodDermatologic Clinics, 2003
- ImiquimodCurrent Opinion in Infectious Diseases, 2003
- Insights into a novel treatment for molluscumActa Paediatrica, 2003
- 3. Successful Management of Viral Infections and Other Dermatoses with Imiquimod 5% CreamPublished by Medical Journals Sweden AB ,2003
- Pediatric Molluscum ContagiosumPediatric Drugs, 2003
- Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potentialClinical and Experimental Dermatology, 2002
- Efficacy of Imiquimod 5% Cream in the Treatment of Recalcitrant Warts in ChildrenPediatric Dermatology, 2002